Active ingredientAmfenacCat. No. P-A112-001CAS 51579-82-9Family · Pharmaceutical analytical standards
Amfenac
A non-steroidal anti-inflammatory drug derived from phenylacetic acid that inhibits the COX-1 and COX-2 cyclooxygenases; it is also the active form of nepafenac, eye drops approved in the US in 2005 for pain and inflammation after cataract surgery. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?Nepafenac is a prodrug: it crosses the cornea and only inside the eye do tissue hydrolases turn it into amfenac. Bromfenac, another eye drop, has the same structure with an extra bromine atom.
Go to the active ingredient →Active ingredientAmfenacCat. No. P-A112-001CAS 51579-82-9
Active ingredientAmfenac Sodium MonohydrateCat. No. P-A112-002CAS 61618-27-7
Active ingredientAmfenac Sodium SaltCat. No. P-A112-003CAS 61941-56-8
MetaboliteAmfenac GlucuronideCat. No. P-A112-004
Isotopically labelledAmfenac-d5Cat. No. P-A112-005
ImpurityAmfenac Impurity 1Cat. No. P-A112-006CAS 78281-75-1
Impurity7-Benzoylindolin-2-oneCat. No. P-A112-007CAS 51135-38-7
ImpurityAmfenac Ethyl EsterCat. No. P-A112-008CAS 61941-57-9
ImpurityAmfenac Methyl EsterCat. No. P-A112-009CAS 61941-58-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.